144 related articles for article (PubMed ID: 38070023)
21. OIP5-AS1 promotes the progression of gastric cancer cells via the miR-153-3p/ZBTB2 axis.
Zhi XH; Jiang K; Ma YY; Zhou LQ
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2428-2441. PubMed ID: 32196594
[TBL] [Abstract][Full Text] [Related]
22. Exosomal Long Non-Coding RNA CEBPA-AS1 Inhibits Tumor Apoptosis and Functions as a Non-Invasive Biomarker for Diagnosis of Gastric Cancer.
Piao HY; Guo S; Wang Y; Zhang J
Onco Targets Ther; 2020; 13():1365-1374. PubMed ID: 32110038
[TBL] [Abstract][Full Text] [Related]
23. Long Non-Coding RNA FGD5-AS1 Induced by
Wen Y; Luo F; Zhao L; Su S; Lei W; Liu Y; Shi K; Li Z
Front Cell Infect Microbiol; 2021; 11():701352. PubMed ID: 34568091
[TBL] [Abstract][Full Text] [Related]
24. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer.
Wang M; Zhang Z; Pan D; Xin Z; Bu F; Zhang Y; Tian Q; Feng X
Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34212174
[TBL] [Abstract][Full Text] [Related]
25. METTL14 promotes tumorigenesis by regulating lncRNA OIP5-AS1/miR-98/ADAMTS8 signaling in papillary thyroid cancer.
Zhang X; Li D; Jia C; Cai H; Lv Z; Wu B
Cell Death Dis; 2021 Jun; 12(6):617. PubMed ID: 34131102
[TBL] [Abstract][Full Text] [Related]
26. Expression profiles and functional prediction of long non-coding RNAs LINC01133, ZEB1-AS1 and ABHD11-AS1 in the luminal subtype of breast cancer.
Mehrpour Layeghi S; Arabpour M; Shakoori A; Naghizadeh MM; Mansoori Y; Tavakkoly Bazzaz J; Esmaeili R
J Transl Med; 2021 Aug; 19(1):364. PubMed ID: 34446052
[TBL] [Abstract][Full Text] [Related]
27. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
Aichen Z; Kun W; Xiaochun S; Lingling T
Apoptosis; 2021 Jun; 26(5-6):348-360. PubMed ID: 33974163
[TBL] [Abstract][Full Text] [Related]
28. Expression Analysis of OIP5-AS1 in Non-Small Cell Lung Cancer.
Esfandi F; Kholghi Oskooei V; Taheri F; Kiani A; Taheri M; Ghafouri-Fard S
Klin Onkol; 2018; 31(4):260-263. PubMed ID: 30541307
[TBL] [Abstract][Full Text] [Related]
29. Circulating lncRNA ABHD11-AS1 serves as a biomarker for early pancreatic cancer diagnosis.
Liu Y; Feng W; Liu W; Kong X; Li L; He J; Wang D; Zhang M; Zhou G; Xu W; Chen W; Gong A; Xu M
J Cancer; 2019; 10(16):3746-3756. PubMed ID: 31333792
[No Abstract] [Full Text] [Related]
30. Circulatinglong non-coding RNA FEZF1-AS1 and AFAP1-AS1 serve as potential diagnostic biomarkers for gastric cancer.
Liu W; Li Y; Zhang Y; Shen X; Su Z; Chen L; Cai W; Wang F; Ju S
Pathol Res Pract; 2020 Jan; 216(1):152757. PubMed ID: 31785996
[TBL] [Abstract][Full Text] [Related]
31. Expression and crucial role of long non-coding RNA FGD5-AS1 in human cancers.
Zhu L; Shi X; Yu X; Wang Z; Zhang M; He Y; Guo W
Am J Transl Res; 2021; 13(10):10964-10976. PubMed ID: 34786036
[TBL] [Abstract][Full Text] [Related]
32. Expression of lncRNA FGD5-AS1 correlates with poor prognosis in melanoma patients.
Gao Y; Zhu H; Mao Q
J Gene Med; 2020 Dec; 22(12):e3278. PubMed ID: 32997827
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer.
Gao J; Cao R; Mu H
Int J Clin Exp Pathol; 2015; 8(10):12936-42. PubMed ID: 26722487
[TBL] [Abstract][Full Text] [Related]
34.
Zhang X; Gao Y; Zhang X; Zhang X; Xiang Y; Fu Q; Wang B; Xu Z
Front Cell Dev Biol; 2021; 9():630634. PubMed ID: 34046402
[TBL] [Abstract][Full Text] [Related]
35. HNF1A-Induced lncRNA HCG18 Facilitates Gastric Cancer Progression by Upregulating DNAJB12 via miR-152-3p.
Ma P; Li L; Liu F; Zhao Q
Onco Targets Ther; 2020; 13():7641-7652. PubMed ID: 32801777
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.
Qi F; Liu X; Wu H; Yu X; Wei C; Huang X; Ji G; Nie F; Wang K
J Hematol Oncol; 2017 Feb; 10(1):48. PubMed ID: 28209205
[TBL] [Abstract][Full Text] [Related]
37. Identification of lncRNA PCAT19 as potential novel biomarker for colorectal cancer.
Masoud A; Mohamadynejad P
Gene; 2024 Jan; 891():147828. PubMed ID: 37748628
[TBL] [Abstract][Full Text] [Related]
38. Development and Validation of a Novel Stemness-Index-Related Long Noncoding RNA Signature for Breast Cancer Based on Weighted Gene Co-Expression Network Analysis.
Qian D; Qian C; Ye B; Xu M; Wu D; Li J; Li D; Yu B; Tao Y
Front Genet; 2022; 13():760514. PubMed ID: 35273635
[No Abstract] [Full Text] [Related]
39. High long non-coding LIFR-AS1 expression correlates with poor survival in gastric carcinoma.
Wang HF; Lv JQ; Li HH; Wang W; Lin FQ
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5378-5384. PubMed ID: 32495872
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatic Analysis and Experimental Validation of HMGA2-AS1 as a Prognostic Biomarker Associated with Immune Infiltration in Gastric Cancer.
Lyu G
Recent Pat Anticancer Drug Discov; 2024 Apr; ():. PubMed ID: 38566377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
